Aptar Pharma, a drug delivery systems provider, has released an industry first, PureHale, a new portable and ready-to-use drug delivery solution designed for upper respiratory care. PureHale, when used in combination with saline or other natural ingredient formulations, is designed to help relieve the symptoms of upper respiratory system conditions.

PureHale will be officially launched at CPhI Worldwide, and is a finalist in the CPhI Pharma Awards in the Excellence in Pharma: Drug Delivery Device category.

PureHale’s technology distributes a continuous fine mist that cleanses, moisturizes and soothes the upper respiratory tract, helping to reduce irritations caused by coughs, colds, allergies, respiratory problems and dry nose/throat issues.

PureHale is portable and was developed after researching and analyzing the benefits and challenges of traditional nebulizer technology. This new system was engineered for on-the-go consumers, and unlike traditional nebulizers, does not require batteries or the prefilling of a reservoir.

Guenter Nadler, director business development at Aptar Pharma, said, “We are really excited to announce this newest Aptar Pharma innovation. We have seen a real need for a device of this kind – traditional nebulizers come with a set of challenges including complexities in setup, manual dexterity requirements and overall usage time. Meanwhile, challenges during medication administration include poor inhalation technique, duration of nebulization and understanding how to achieve optimal efficacy. PureHale has been designed specifically with these challenges in mind and offers a solution by simplifying the entire process.”